Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

2017 ◽  
Vol 32 (7) ◽  
pp. 229-238 ◽  
Author(s):  
Ines De Pauw ◽  
An Wouters ◽  
Jolien Van den Bossche ◽  
Vanessa Deschoolmeester ◽  
Hasan Baysal ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document